SAHCS Guidelines





Southern African HIV Clinicians Society guidelines for solid organ transplantation in human immunodeficiency virus: An evidence-based framework for human immunodeficiency virus-positive donors and recipients

Nel JS, Conradie F, Botha J, et al.

  • 15 Oct 2020

These guidelines, intended for transplantation healthcare practitioners in Southern Africa, seek to sketch an evidence-based framework for human immunodeficiency virus (HIV)-positive donors and recipients regarding solid organ transplantation. The guidelines include considerations for the transplantation of organs from HIV-positive donors to HIV-negative recipients. Donor and recipient eligibility, HIV transmission risks and ethical considerations are discussed.











Adult antiretroviral therapy guidelines 2017

  • 14 Jul 2017

These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2014 and the update on when to initiate antiretroviral therapy in 2015. Since the release of the previous guidelines, the scale-up of antiretroviral therapy (ART) in southern Africa has continued. New antiretroviral drugs have become available with improved efficacy, safety and more robustness. The guidelines are intended for countries in the southern African region, which vary between lower and middle income.




Corrigendum: 2015 Society PEP Guidelines

  • 03 Mar 2016

This document is a corrigendum to our "Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update".





Guidelines for the Delivery of Antiretroviral Therapy to Migrants and Crisis-Affected Persons in Sub-Saharan Africa

  • 17 Apr 2015

Update to 2007 guidance to include all types of migrants and crisis-affected populations, including those forcibly displaced. This update stresses that migration and forced displacement must NO T be used as an excuse to deny treatment. Clear recommendations are provided for states, clinicians and programme managers, civil society, donors and United Nations (UN ) agencies.



































Interim guidance

  • 18 Jul 2019

Interim guidance while abacavir/lamivudine, abacavir singles, lamivudine singles and abacavir/zidovudine (2nd Line) are out of stock updated 18.07.2019


Interim guidance

  • 11 Oct 2018

Interim guidance while abacavir/lamivudine, abacavir singles and lamivudine singles (2nd Line) are out of stock


Stockouts advice - AZT/3TC

  • 20 Sep 2018

Interim guidance while abacavir/lamivudine, abacavir singles and lamivudine singles are out of stock